Copyright
©The Author(s) 2023.
World J Hepatol. Dec 27, 2023; 15(12): 1284-1293
Published online Dec 27, 2023. doi: 10.4254/wjh.v15.i12.1284
Published online Dec 27, 2023. doi: 10.4254/wjh.v15.i12.1284
Table 2 Transarterial radioembolization induced toxicities
| Paper | Mild to moderate (grade 1-2) | Severe (grade 3-4) | ||
| Biochemical (%) | Constitutional (%) | Biochemical (%) | Constitutional (%) | |
| Ibrahim et al[26], 2008 | - | Fatigue (75); Abdominal pain (38); vomiting (13); anorexia (8) | Albumin (17); Bilirubin (4) | Gastroduodenal Ulcer (4); Ascites (14); Pleural effusion (9) |
| Gangi et al[15], 2018 | (53) | Fatigue (42.3); Abdominal Pain (18.8); Weight loss (7.1); Ascites (5.9) | Bilirubin and Alkaline phosphatase elevation (9) | Liver abscess (2) |
| Pellegrinelli et al[27], 2021 | - | - | - | Cholecystitis and angiocholitis (2.85) |
| Robinson et al[14], 2022 | - | - | Bilirubin (10.5), Albumin (2.6), AST increase (7.8), ALT increase (5.2) | Abdominal pain, Cholecystitis (4.1) |
- Citation: Elvevi A, Laffusa A, Elisei F, Morzenti S, Guerra L, Rovere A, Invernizzi P, Massironi S. Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? World J Hepatol 2023; 15(12): 1284-1293
- URL: https://www.wjgnet.com/1948-5182/full/v15/i12/1284.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i12.1284